Novavax Announces Completion of Construction of Vaccine Production Facility in India

ROCKVILLE, Md., June 10 /PRNewswire-FirstCall/ — CPL Biologicals (CPLB), a joint venture of Cadila Pharmaceuticals Ltd. and Novavax, Inc.

Share this article

Leave a Reply

Your email address will not be published. Required fields are marked *